Published in Kidney Int on October 01, 2004
Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988-2010. Clin J Am Soc Nephrol (2012) 2.39
Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis (2014) 2.16
Percutaneous renal biopsy of native kidneys: efficiency, safety and risk factors associated with major complications. Arch Med Sci (2011) 1.08
Predictors of complication after percutaneous ultrasound-guided kidney biopsy in HIV-infected individuals: possible role of hepatitis C and HIV co-infection. Clin J Am Soc Nephrol (2009) 1.03
Magnetic resonance imaging with hyperpolarized [1,4-(13)C2]fumarate allows detection of early renal acute tubular necrosis. Proc Natl Acad Sci U S A (2012) 1.01
Ultrasonography as a predictor of overt bleeding after renal biopsy. Clin Exp Nephrol (2009) 0.96
Renal biopsy practice: What is the gold standard? World J Nephrol (2014) 0.96
Percutaneous ultrasound-guided renal biopsy: A Libyan experience. Indian J Nephrol (2010) 0.90
Predictors of kidney biopsy complication among patients with systemic lupus erythematosus. Lupus (2012) 0.88
The incidence of major hemorrhagic complications after renal biopsies in patients with monoclonal gammopathies. Clin J Am Soc Nephrol (2010) 0.88
RNA Sequencing Identifies Novel Translational Biomarkers of Kidney Fibrosis. J Am Soc Nephrol (2015) 0.88
Performance of Biopsy Needle With Therapeutic Injection System to Prevent Bleeding Complications. J Med Device (2013) 0.82
The contemporary role of renal mass biopsy in the management of small renal tumors. Front Oncol (2012) 0.81
A compendium of urinary biomarkers indicative of glomerular podocytopathy. Patholog Res Int (2013) 0.81
Proteomic profiling of nephrotic syndrome in serum using magnetic bead based sample fractionation & MALDI-TOF MS. Indian J Med Res (2012) 0.81
Noninvasive prognostication of polyomavirus BK virus-associated nephropathy. Transplantation (2013) 0.80
Relationship between hospital volume and hemorrhagic complication after percutaneous renal biopsy: results from the Japanese diagnosis procedure combination database. Clin Exp Nephrol (2014) 0.79
Factors that can minimize bleeding complications after renal biopsy. Int Urol Nephrol (2014) 0.79
The Native Kidney Biopsy: Update and Evidence for Best Practice. Clin J Am Soc Nephrol (2015) 0.78
Percutaneous native kidney biopsy in patients receiving antiplatelet agents- is it necessary to stop them routinely? Indian J Nephrol (2015) 0.78
Biopsy: observation time after kidney biopsy: when to discharge? Nat Rev Nephrol (2009) 0.76
Application of Proteomic Analysis to Renal Disease in the Clinic. Proteomics Clin Appl (2009) 0.76
Does systematic preliminar colour Doppler study reduce kidney biopsy complication incidence? Int J Nephrol (2011) 0.75
Absorption fever characteristics due to percutaneous renal biopsy-related hematoma. Medicine (Baltimore) (2016) 0.75
A prospective audit of complications in 100 consecutive pediatric percutaneous renal biopsies done under real-time ultrasound guidance. Indian J Nephrol (2016) 0.75
Achieving Procedural Competence during Nephrology Fellowship Training: Current Requirements and Educational Research. Clin J Am Soc Nephrol (2016) 0.75
Fumarase activity: an in vivo and in vitro biomarker for acute kidney injury. Sci Rep (2017) 0.75
Effects of Aspirin Therapy on Ultrasound-Guided Renal Allograft Biopsy Bleeding Complications. J Vasc Interv Radiol (2016) 0.75
Clinicopathological Spectrum of Renal Biopsies in Children. Med J Armed Forces India (2011) 0.75
Percutaneous native renal biopsy adequacy: a successful interdepartmental quality improvement activity. Can J Kidney Health Dis (2015) 0.75
Quantification of bleeding volume using computed tomography and clinical complications after percutaneous renal biopsy. Clin Kidney J (2017) 0.75
[Hemorrhagic shock following a renal biopsy: report of a case]. Pan Afr Med J (2015) 0.75
Clinical factors influencing the decision to transfuse after percutaneous native kidney biopsy. Clin Kidney J (2015) 0.75
Biomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic review. BMC Nephrol (2017) 0.75
Bleeding complications post ultrasound guided renal biopsy - A single centre experience from Pakistan. Ann Med Surg (Lond) (2017) 0.75
Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med (2005) 7.83
Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med (2007) 4.23
Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol (2006) 3.95
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ (2009) 3.83
Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.78
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.62
The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. Am J Kidney Dis (2008) 3.45
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int (2014) 3.40
Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review. Am J Kidney Dis (2005) 3.37
The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol (2004) 3.30
Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet (2011) 3.15
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97
Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol (2009) 2.70
Regenerative potential of embryonic renal multipotent progenitors in acute renal failure. J Am Soc Nephrol (2007) 2.42
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2014) 2.35
Desmopressin acetate in percutaneous ultrasound-guided kidney biopsy: a randomized controlled trial. Am J Kidney Dis (2011) 2.27
Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J Exp Med (2008) 2.25
Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression. J Am Soc Nephrol (2006) 2.24
Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol (2013) 2.22
HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev (2013) 2.21
Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol (2005) 2.18
Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review. PLoS One (2013) 2.10
Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet (2005) 2.09
Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2009) 2.04
Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. J Exp Med (2002) 1.95
Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis (2010) 1.81
The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int (2013) 1.75
Retracted Human renal stem/progenitor cells repair tubular epithelial cell injury through TLR2-driven inhibin-A and microvesicle-shuttled decorin. Kidney Int (2013) 1.75
Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy. J Am Soc Nephrol (2012) 1.73
A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis (2007) 1.73
Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet (2012) 1.69
Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial. Transplantation (2011) 1.66
Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev (2014) 1.63
Systemic inflammation, metabolic syndrome and progressive renal disease. Nephrol Dial Transplant (2009) 1.63
Copy-number disorders are a common cause of congenital kidney malformations. Am J Hum Genet (2012) 1.63
Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis (2004) 1.62
Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study. Nephrol Dial Transplant (2012) 1.61
Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev (2014) 1.61
Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway. Nephrol Dial Transplant (2014) 1.61
Postconditioning is an effective strategy to reduce renal ischaemia/reperfusion injury. Nephrol Dial Transplant (2008) 1.57
Sexual dysfunction in women with ESRD requiring hemodialysis. Clin J Am Soc Nephrol (2012) 1.56
Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation (2009) 1.56
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Cochrane Database Syst Rev (2014) 1.55
Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int (2013) 1.52
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2009) 1.52
miR-1915 and miR-1225-5p regulate the expression of CD133, PAX2 and TLR2 in adult renal progenitor cells. PLoS One (2013) 1.52
Addition of the multidimensional prognostic index to the estimated glomerular filtration rate improves prediction of long-term all-cause mortality in older patients with chronic kidney disease. Rejuvenation Res (2012) 1.51
Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. Clin J Am Soc Nephrol (2012) 1.51
Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy. Kidney Int (2012) 1.46
Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients. Transplantation (2003) 1.46
Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian Renal Immunopathology Group. Nephrol Dial Transplant (2004) 1.46
Monitoring biological action of rapamycin in renal transplantation. Am J Kidney Dis (2007) 1.43
Cigarette smoking is associated with low glomerular filtration rate in male patients with type 2 diabetes. Diabetes Care (2006) 1.43
Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. CMAJ (2013) 1.43
Management of side effects of sirolimus therapy. Transplantation (2009) 1.43
Biosimilars and safety issues. Leuk Lymphoma (2009) 1.40
Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. Mol Immunol (2007) 1.39
Kinetics of the circulating levels of bone alkaline phosphatase in a case of hungry bone disease following total parathyroidectomy. Ann Ital Med Int (2004) 1.39
Sevelamer: a promising but unproven drug. Nephrol Dial Transplant (2007) 1.39
Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J Am Soc Nephrol (2004) 1.37
TLR2 plays a role in the activation of human resident renal stem/progenitor cells. FASEB J (2009) 1.33
Trial quality in nephrology: how are we measuring up? Am J Kidney Dis (2011) 1.32
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. Am J Kidney Dis (2009) 1.31
Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens. J Proteomics (2011) 1.28
Exome sequencing identified MYO1E and NEIL1 as candidate genes for human autosomal recessive steroid-resistant nephrotic syndrome. Kidney Int (2011) 1.22
Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials. Nephrology (Carlton) (2004) 1.21
CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS). Nephrol Dial Transplant (2009) 1.21
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol (2005) 1.19
WT1 mutations in nephrotic syndrome revisited. High prevalence in young girls, associations and renal phenotypes. Pediatr Nephrol (2006) 1.16
Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal. J Am Soc Nephrol (2004) 1.12
Occult HBV infection in hemodialysis setting is marked by presence of isolated antibodies to HBcAg and HCV. J Nephrol (2009) 1.10
Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy. Diabetes Care (2010) 1.09
Cardiovascular diseases: Lipid-lowering in CKD--at the SHARP end of the evidence? Nat Rev Nephrol (2011) 1.08
Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study. Clin J Am Soc Nephrol (2007) 1.08
Antiplatelet agents for chronic kidney disease. Cochrane Database Syst Rev (2013) 1.08
Goodpasture's disease: a report of ten cases and a review of the literature. Autoimmun Rev (2013) 1.05
Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients. J Am Soc Nephrol (2005) 1.04
Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination. Transplantation (2002) 1.04
Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression. Transpl Int (2008) 1.04
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database Syst Rev (2014) 1.03
Urinary epidermal growth factor, monocyte chemotactic protein-1, and β2-microglobulin in children with ureteropelvic junction obstruction. J Pediatr Surg (2011) 1.02
An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism. Am J Kidney Dis (2003) 1.02
Characterization of two novel missense mutations in the AQP2 gene causing nephrogenic diabetes insipidus. Nephron Physiol (2006) 1.02
Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy. Proteomics (2008) 1.02
Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials. Am J Kidney Dis (2005) 1.01
Association between depression and death in people with CKD: a meta-analysis of cohort studies. Am J Kidney Dis (2013) 1.01
Urine profiling by SELDI-TOF/MS: monitoring of the critical steps in sample collection, handling and analysis. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 1.01
Para- and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients. Nephrol Dial Transplant (2010) 1.01
Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Med (2013) 1.01
Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma. Int J Cancer (2008) 1.00
Antihypertensive agents for primary prevention of diabetic nephropathy. J Am Soc Nephrol (2005) 0.99
Immune modulation of human dendritic cells by complement. Eur J Immunol (2007) 0.99
Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials. J Am Soc Nephrol (2004) 0.98
Treatment for lupus nephritis. Cochrane Database Syst Rev (2012) 0.98